▲ Peaking
Business
Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies
Boulevard Bio launches with significant backing to advance precision immunology pipeline.
2 trends tracked about this subject — the full history, oldest to newest below.
Boulevard Bio launches with significant backing to advance precision immunology pipeline.
Deerfield-backed startup Boulevard Bio launches with a $65 million seed to pursue a trio of targeted immunology drugs.